🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Lapatinib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
UCSF Helen Diller Family Comprehensive Cancer Center
Start Date
2007-08
Trial ID
NCT00544804
Treatments Being Tested
This study was originally designed as a Phase III randomized, double blind,...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2005-12-13
Trial ID
NCT00272987
Treatments Being Tested
This retrospective cohort study aims to improve our understanding of the cu...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-05-06
Trial ID
NCT01064349
Objectives: Phase I part * Primary Objective: To determine the recommende...
Status
Terminated
Location
China Medical University Hospital
Start Date
2012-07
Trial ID
NCT01658358
The purpose of this study is to evaluate the efficacy of the implementation...
Status
Terminated
Location
Centre Jean Perrin
Start Date
2011-09-06
Trial ID
NCT01847599
A study to compare the safety and efficacy of an aromatase inhibitor in com...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-05-05
Trial ID
NCT01160211
Treatments Being Tested
The objective of this phase I/ II study is therefore to assess the safety a...
Status
Completed
Location
Centre Georges François Leclerc
Start Date
2008-11
Trial ID
NCT01044485
This pilot clinical trial studies the feasibility of choosing treatment bas...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2015-09-11
Trial ID
NCT02551718
This phase II trial studies how well lapatinib ditosylate works in treating...
Status
Completed
Location
University of Virginia
Start Date
2005-03
Trial ID
NCT00114283
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as capecitabine, work in differ...
Status
Completed
Location
Abramson Cancer Center of The University of Pennsylvania
Start Date
2009-10
Trial ID
NCT01044433
Treatments Being Tested